Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollars

Exit of Animal Health business completes the series of portfolio measures initiated by Bayer in November 2018 ahead of announced schedule / Enhances Bayer’s focus as a global leader in life sciences

Source: Bayer Company News - August 20, 2019 Category: Pharmaceuticals Source Type: news